Serum VEGF and sPD-L1 are recognized as predictive biomarkers for various types of cancer (Chivu-Economescu et al. 2023; Goncharuk et al. 2009; Jovanović et al. 2019; Mathur et al. 2005). This evidence concerns the gene SPDL1 and cancer.